High Quality Content by WIKIPEDIA articles! MannKind Corporation (NASDAQ: MNKD), based in Valencia, California, is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer. The company, while technically founded in February 1991, took its present form in 2003 as a merger of three companies owned by Alfred E. Mann, named after its founder in an attempt at humor. One of the former companies, Pharmaceutical Discovery, was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone Inhaler, upon which was developed its lead product, Afrezza (inhalable insulin), which was under FDA review. Alfred Mann is chairman of the board and chief executive officer. Mann has invested approximately $900 million in his company. Данное издание представляет собой компиляцию сведений, находящихся в свободном доступе в среде Интернет в целом, и в...

В наличии:
	Books.Ru - 1128 руб.	Перейти
Под заказ:
	OZON.ru - 1125 руб.	Перейти

Рейтинг книги: 5 из 5, 8 голос(-ов).